<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN""http://www.w3.org/TR/html4/loose.dtd"><html><head><title>Norsk legemiddelh�ndbok</title><LINK rel="stylesheet" href="css/stylesheet.css"><script type="text/javascript" src="lib/tableruler.js"></script>
<script type="text/javascript">
window.onload=function(){tableruler();}</script>
</head><body><p class = "gruppenavn">L01XE08_1, Nilotinib -  Kapsel </p><p class = "berettigetbruk">Refusjonsberettiget bruk:</p><p class = "bruk">Kronisk fase og akselerert fase Philadelphiakromosom positiv KML med resistens eller intoleranse overfor tidligere behandling, inkludert imatinib.</p><table class = "hoved" border = "0"><tr><td valign = "top"><p class = "refkode">Refusjonskode:</p><table class = "Tabell-A"><tr><th>ICPC</th><th>Beskrivelse</th><th>Vilk�r nr.</th></tr><tbody><tr><td>B73</td><td>Leukemi myelogen kronisk</td><td>-  </td></tr></tbody></table></td><td valign = "top"><p class = "refkode">Refusjonskode:</p><table class = "Tabell-A"><tr><th>ICD</th><th>Beskrivelse</th><th>Vilk�r nr.</th></tr><tbody><tr><td>C92.1</td><td>Kronisk myelogen leukemi (M 9863/3)</td><td>-  </td></tr></tbody></table></tr><tr colspan = "2"><td colspan = "2"><table class = "Tabell-A"><tr><td>Vilk�r</td></tr><tr><td>Ingen spesifisert</td></tr></table></td></tr></table><p class = "berettigetbruk">Refusjonsberettigede preparater:</p><ul><li>Tasigna Kaps 200 mg 112stykk<i> - Blisterpakning</i></li></ul><br><br><br><center><input type="button" value="Lukk vindu" onclick="window.close()"></center><br></body></html>